Denosumab in Treating Patients With Recurrent or Refractory Osteosarcoma

NCT02470091 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

56

Enrollment

NETWORK

Sponsor class

Conditions

Metastatic Osteosarcoma
Recurrent Osteosarcoma
Refractory Osteosarcoma
Stage IV Osteosarcoma AJCC v7
Stage IVA Osteosarcoma AJCC v7
Stage IVB Osteosarcoma AJCC v7

Interventions

BIOLOGICAL: Denosumab
OTHER: Laboratory Biomarker Analysis
OTHER: Pharmacological Study

Sponsor

Children's Oncology Group

Collaborators

[object Object]